RxDoctor Payments Data

Jane Jurma

Pediatrics · Jasper, GANPI 1649777947

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 26.7% of the total. Reporting peaked in 2024 at $402 and has fallen 87.7% since, to $49 in 2025.

$921in general payments, 2019–2025

Across 54 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$246
  • GSK$99
  • Takeda Pharmaceuticals U.S.A., Inc.$57
  • Exact Sciences$48
  • Ironshore Pharmaceuticals Inc.$43
  • Corcept Therapeutics$34
  • plus $393 from 19 others

What the payments were for

  • Food & beverage$90899%
  • Other$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$921 in reported general payments places this provider in the 80th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Jasper

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →